• Written by ajiang
  • June 14, 2010 at 2:38 am
  • Gershon Capital provides advisory services to healthcare and life science companies through its relationship with Gershon & Company, our consulting arm founded in 1999. The Gershon & Company advisory group leverages its senior management team and industry networks to bring sector expertise, investment experience, and regulatory, scientific and medical knowledge to emerging healthcare and life science companies, hedge funds, private equity firms, and government.

    The transition from clinical development to commercial operations can be a daunting task for emerging life science companies. The many challenges include strategic business planning, organizational development, new product launch planning, commercial marketing services, business process development, supply chain distribution strategy/execution, regulatory compliance, branding/positioning strategies and others. The key to successful commercialization requires a full understanding the functional activities across the business spectrum necessary to build and execute a comprehensive business plan. Gershon Capital will work closely with your management team to ensure your organization is fully engaged and has the foundation to make the critical decisions ensuring your company’s vision for success is realized.

    For more information, contact:

    Dean Erhardt, Director of Marketing and Licensing


  • Conference Info:


    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City

    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!